Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42226 (
Signal transducer and activator of transcription 6
)
35
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Germ line C transcripts can be induced by IL-4 in the human B cell line, BL-2. Utilizing a IFN-gamma activation site-like DNA sequence element located upstream of the I epsilon exon, we demonstrated by gel mobility shift assays that IL-4 induced a binding activity in the cytosol and nucleus of BL-2 cells. This factor was designated IL-4 NAF (IL-4-induced nuclear-activating factors) and was identified as a tyrosine phosphoprotein, which translocates from the cytosol to the nucleus upon IL-4 treatment. Because these are the characteristics of a signal transducer and activator of transcription (Stat) protein, we determined whether antibodies to Stat proteins will interfere with gel mobility shift and found that antibodies to
IL-4 Stat
, also known as Stat6, but not antibodies to other Stat proteins, interfere with the formation of the IL-4 NAF complex. Congruous with the involvement of a Stat protein, IL-4 induced robust Janus kinase 3 (JAK3) activity in BL-2 cells. Cotransfection of JAK3 with
IL-4 Stat
into COS-7 cells produced an intracellular activity which bound the same IFN-gamma activation site-like sequence and comigrated with IL-4 NAF in electrophoretic mobility shift assay. These results show that IL-4 NAF is
IL-4 Stat
, which is activated by JAK3 in response to IL-4 receptor engagement.
J
Clin
Invest 1995 Aug
PMID:Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. 763 85
Signal transducer and activator of transcription 6
(
STAT6
) is essential for the biological activities of interleukin-4 (IL-4) and the development of allergic responses in mice. Here we report on a sensitive and specific assay for
STAT6
activation in response to IL-4. We took advantage of double-stranded oligonucleotide probes containing a
STAT6
-binding gene-sequence from the promotor of the immunoglobulin heavy chain germline epsilon transcript to study the IL-4-induced DNA binding of
STAT6
. Using these probes, we show that repeated adjacent
STAT6
-binding sites result in enhanced
STAT6
-DNA binding. Moreover, the distance between the binding sites is critical for STAT-DNA binding, i.e.
STAT6
binding is decreased at distances above 20 nucleotides between neighbouring binding sites. Using this assay to study cross-talk between IL-4 and chemokines, we provide evidence that MIP-1beta and MIG inhibit IL-4-induced
STAT6
activation, whereas other chemokines and cytokines do not. In conclusion, our data show that oligonucleotide fishing is a supplementary tool for studying cytokine cross-talk at a genomic level.
Exp
Clin
Immunogenet 2001
PMID:Oligonucleotide fishing for STAT6: cross-talk between IL-4 and chemokines. 1187 54
Signal transducer and activator of transcription 6
(
STAT6
) is a key transcription factor involved in interleukin 4 (IL-4) and IL-13-mediated Th2 response. The
STAT6
gene is located on chromosome 12q13.3-14.1 (IBD2 region) and is therefore a positional and functional candidate gene for study in inflammatory bowel disease. We investigated the G2964A polymorphism in the 3' untranslated region of the
STAT6
gene in Dutch patients with inflammatory bowel disease and healthy controls. The G2964A polymorphism in the
STAT6
gene was genotyped in 141 unrelated Dutch Caucasian patients with ulcerative colitis, 183 patients with Crohn's disease and 173 healthy individuals by PCR and the amplification-created restriction site method. Patients with Crohn's disease were classified according to the Vienna classification and the patients with ulcerative colitis were classified with the age at onset, extent of disease and colectomy. We did not find significant differences in genotype and allele frequencies of the G2964A polymorphism in the
STAT6
gene between ulcerative colitis, Crohn's disease and healthy controls. Subgroups of the patients with Crohn's disease classified according to the Vienna classification and those with ulcerative colitis classified according to age of onset, disease extension and colectomy did not differ in the distribution of this polymorphism. The
STAT6
G2964A gene polymorphism is not involved in the overall susceptibility or in determining the phenotype of IBD.
Clin
Exp Immunol 2003 Mar
PMID:Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease. 1260 97